chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was vaccinated and I get COVID; I was vaccinated and I get COVID; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old patient received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "I was vaccinated and I get COVID". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Clinical course: Patient had a quick question. Patient was vaccinated (further clarifications unknown hence, captured as unspecified vaccine) and patient got COVID and took a five day course of Paxlovid and they had no adverse reaction, worked very good, worked very well but patient's question was they were 71 years old, their doctor told to stop taking their statin drug (Unspecified medication) for cholesterol. Patient's question was they took the last dosage tonight, five days. How long does patient have to wait before they get start taking their statin drug again.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given 0.5ml instead of 0.25ml, patient was called and states had cold symptoms for 1 day , the same as the 2nd dosage of Moderna, and no other problems since a letter was also sent to the patient with the dosage given
Dizziness and lips started tingling immediately after shot.  Later in the evening, severe pain in arm, unable to lift arm.  The next day, arm still sore, unable to lift, nauseous, fever, fatigue.  Later that night, pain, itchy, burning sensation in  left arm near injection site, then later in lower left leg.  Nauseous for three days, diarrhea three days later.
Patient received second dose of murderer vaccine on October 1.  That night he developed low-grade fevers, chills, body aches, which resolved after 2 days.  However on the morning of October 5, he woke up with acute onset chest pain.  He presented to the hospital with persistent chest pain and significant troponin elevation.  EKG with nonspecific findings.  Echocardiogram is still pending.  Chest pain resolved spontaneously while in the emergency department.  Awaiting echocardiogram and cardiac MRI results.
Adverse Event:  Prepared vaccination vial  prepared 01/04/2022 ,  however labeled with 01/05/2022.   Dose given today from the vial labeled as 1/5/2022 , however expiration time alerted RN  the vial had Expired. Upon discovery of the expiration , this patient was present with physician  and explained the situation to both PCP and patient. Patient agreed to receiving another dose with a VIABLE vaccination ;prepared and labeled correctly.
Burning Sensation in the Right Eye; Itchy around Right Eye; Swollen Face; Drooping Right Eye; Red Face; Headache; A spontaneous report was received from a consumer concerning a 52-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events burning sensation in the right eye, itchy around right eye, swollen face, red face, drooping right eye, headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 027L20A) Intramuscularly in left upper arm for prophylaxis of COVID-19 infection.  On 13 Jan 2021, the patient experienced the event(s) burning sensation in the right eye, itchy around right eye, swollen face, red face, drooping right eye, headache. These symptoms started at her eye and migrated down half of her neck.  Treatment for events included 2 Benadryl (50 mg Total) and Elocon cream to relieve side effects.  On 14 JAN 2021, The symptoms seemed to get worsen, The patient spoke to her physician prescribed her medrol dose pack and Atarax. The medication seemed to help her symptoms, but she was still experiencing mild symptoms.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), burning sensation in the right eye, itchy around right eye, swollen face, red face, drooping right eye, headache was considered as not esolved.; Reporter's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 54-year-old male patient who received SHINGRIX (batch number 32GR4 ?, expiry date 4th July 2020). On 18th May 2018, 13:55, the patient received the 2nd dose of SHINGRIX (intramuscular). On 18th May 2018, less than a day after receiving SHINGRIX, the patient experienced fever, feeling irritated, influenza-like symptoms, general malaise and joint pain. on 19th May 2018, the outcome of the fever, feeling irritated, influenza-like symptoms, general malaise and joint pain were recovered/resolved. The reporter considered the fever, feeling irritated, influenza-like symptoms, general malaise and joint pain were recovered/resolved. The reporter considered the fever, feeling irritated, influenza-like symptoms, general malaise and joint pain to be related to SHINGRIX. Additional details were provided as follows: The pharmacist reported on online chat. The patient was administered SHINGRIX in the left deltoid. The patient experienced joint pain, felt cranky, flu-like symptoms along with feeling general malaise and feverish.
Flu vaccine given in upper left arm made arm stiff and hard to lift past the shoulder.  I still can?t lift my arm past my shoulder and it?s been approximately 6 weeks.
UNUSUAL TASTE IN MOUTH; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced unusual taste in mouth. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unusual taste in mouth was not reported. This report was non-serious. This case, from the same reporter is linked to 20220130564.
Severe pain; Soreness of both hands. It was difficult to hold onto a full coffee mug with both hands. My right hand still hurts if fingers are squished together, 4 weeks after 2nd dose of vaccine.; Aching of lower back; Aching of lower back, sacroiliac joints; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 10:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included reitners syndrome, reactive arthritis, kidney disease and shellfish allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient experienced severe pain, aching, soreness of both hands. It was difficult to hold onto a full coffee mug with both hands, aching of lower back and sacroiliac joints. These symptoms lasted 2 to 3 weeks. His right hand still hurts if fingers were squished together, 4 weeks after second dose of vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of these events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) at bed time to afford sleeping. The clinical outcome of the events severe pain, aching, soreness of both hands, difficult to hold onto a full coffee mug with both hands, aching of lower back, sacroiliac joints and his right hand still hurts if fingers were squished together was recovered with lasting effects.  No follow-up attempts are needed. No further information is expected.
Joint and muscle pain, requiring analgesic, includ hydrocodone, for 2+weeks, knee and elbow braces.
Patient had CXR with chronic interstitial lung changes with patchy bibasilar opacifications. His troponin was elevated and remained flat. WBC was elevated at 12 with neutrophilia. procalcitonin is 0.4. He was given a dose of IV lasix and was started on treatment for CAP with Ceftriaxone and azithromycin. Started on IV steroids. urine Strep pneumonia was positive. Treated and discharged. This visit was within 6 weeks of receiving the COVID vaccine.
Client received vaccine before 18th birthday (was 17 years, 10 months old).  No reports of adverse symptoms.
Flu like symptoms; achy, soreness, low grade fever; sore arm at injection site. My arm was red for about 4-5 inches around the injection site with notable puffiness swelling about 5 inches below the injection site similar to an allergic reaction.
no adverse event; improper storage of product in use; This spontaneous report was received from a nurse refers to a 10-week-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies, historical drugs and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with first dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, route, lot/batch # and expiration date were not reported) for prophylaxis.   On 17-FEB-2020, the patient was vaccinated with improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) dose 2, (lot # S023219 with expiry date: 03-MAR-2022) via intramuscular route for prophylaxis (product storage error). The vaccine was exposed to a temperature above 47 degrees Fahrenheit (51.87 Fahrenheit) for 2 hours and 15 minutes. There was no previous temperature excursion. It was reported that the call was because of digital data logger. The patient experienced no adverse event. No product quality complaint (PQC) was involved.  This is one of the two reports from the same reporter.
pain of muscle/nerve, neck, arm, and upper back. Very tender arm at injection site and knot at injection site. Put on Prednisone and Mobic by doctor after exam of site and pain. 7/19/07-records received-notes from 3/4/07-C/O pain in neck and difficulty moving her head. Received injection in right arm. Symptoms were worse next day, thought it might be neuritis and was started on Medrol dose pack. Pain also in  left shoulder and her entire body hurts. Instructed if symptoms increased to go to ED.
Redness, soreness. Swelling (L) upper arm. Seen in office by M.D. Rx. BENADRYL as needed, MEDROL dose pack, ULTRAVATE cream locally. Pt called on 5/14/13 and said symptoms had resolved.
This case was reported by a healthcare professional and described the occurrence of local reaction at injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of FLUARIX in an unknown deltoid. Within one day of vaccination, the subject experienced a local reaction at the injection site with injection site redness and injection site pain. Drowsiness was also reported. The subject additionally experienced left arm pain which radiated to the chest. At the time of reporting the outcome of the events was unspecified. The nurse reported that 7 employees of the nursing home received FLUARIX and experienced a local injection site reaction within one day from vaccination. The local reactions ranged from local redness and pain at the injection site to left arm pain which radiated to the chest in one subject and left arm pain which radiated down the arm in another subject. No additional information was provided at the time of reporting. Linked cases include A0809349A, A0809357A through A0809359A and A0809362A.
This spontaneous report was received from a healthcare worker concerning to a 23 years old female patient with penicillin allergy. The patient was vaccinated with the first dose 0.5 ml GARDASIL (lot not provided) approximately in October 2006 (6 yeas ago) when the patient was 17 years old. No other co-suspects were reported. No concomitant medications were reported. The caller reported that the patient was vaccinated IM with the second dose of 0.5 ml GARDASIL (lot number H011350 exp. Date: 21-FEB-2015) on 02-OCT-2012 and had a reaction. Next day on 03-OCT-2012, the patient developed hives on her back and her chest, and a rash on her body. The patient called the doctor office on the night of 03-OCT-2012 and the treatment recommended was over the counter BENADRYL. On follow up call to the patient the next day, the patient told the healthcare worker that when she took BENADRYL the hives/rash disappeared. The reporter stated that the patient when was vaccinated with the first dose of 0.5 ml GARDASIL she had no adverse effects after that first dose. At the time of the report the patient was recovering from the events. The relatedness for hives on her back and her chest and patient developed "rash on her body" is unknown for GARDASIL. Additional information has been requested.
Malaise, auto immune reaction where I developed a rash over body, headache, arthritis in all all joints.  Congestion in chest.
Case number PHEH2012US013853 is an initial spontaneous report received from a physician on 10 Jul 2012. This case refers to a 16-year-old male patient. He was vaccinated with MENVEO vaccine (batch number: X11042/A11042) intramuscularly on 09 Jul 2012. On the same day he experienced paleness, shortness of breath and stiffness. The outcome of these events was reported as unknown. No other information was available.
It started out as spotting on Thursday night, and Friday morning it was bleeding. And that got heavier into Friday and Saturday and then Sunday and Monday it got lighter. And then the bleeding stopped Wednesday or Thursday of this week. By Thursday it was completely gone. I haven't had a period in 3 years due to menopause. I had a tiny bit of cramping, and my breasts were a little sore, so it was kind of like having a period, but those symptoms were not that bad.
got my shots, still have shingles; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient got the shots and still had Shingles. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.
Fever.  Chills.  Headache, irregular heartbeat, nausea, dizziness, body pain, fatigue
pt recv vax & 2-3min p/vax pt became limp, rigid, & eyes rolled back, pt unresponsive;episode lasted 5-10 sec;pt then aroused, crying able to tell RN name, skin pale & diaphoretic;pt waited 15 min longer, resting on moms lap;cheeks pink
12/27/2022 I've lost hearing in left and the right ear has been restricted.
cold symptoms; nasal congestion; This spontaneous case was reported by an other health care professional and describes the occurrence of NASOPHARYNGITIS (cold symptoms) and NASAL CONGESTION (nasal congestion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOFACITINIB CITRATE (XELJANZ XR) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   In 2017, the patient started TOFACITINIB CITRATE (XELJANZ XR) (Oral) 11 milligram once a day. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold symptoms) and NASAL CONGESTION (nasal congestion). At the time of the report, NASOPHARYNGITIS (cold symptoms) and NASAL CONGESTION (nasal congestion) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. The patient missed doses once every three weeks due to forgetting; unaware. The patient completed two doses of COVID vaccine Moderna (unknown, exact dates). the last COVID-19 vaccine was on May 2021 therapy, was held for one week for each dose with no symptoms were reported due to the vaccine/missed doses. Patient was getting over with cold symptoms (new-onset), nasal congestion on unknown dates and was improving. No other symptoms were noted. No treatment medication reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Information has been received from a female health professional in her 40's who "reacts badly to tetanus", and who in 1996 was vaccinated with a dose of measles virus vaccine live (Endors-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). *On the second night post vaccination*, in 1996, the patient experienced pain in her deltoid, a circle, 4-5 inches in diameter, around the immunization site, a generalized rash over her entire body, and a fever of 103F. It was reported that the patient messed a week of work. Subsequently, the patient recovered. Medical attention was not sought. No product quality complaint was involved.  Additional information has been requested.
Case number PHEH2015US021006, is an initial spontaneous report from a nurse received on 13 Oct 2015. This report refers to a 16-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUCELVAX (batch number: not reported) intramuscularly on an unknown date. The patient did not experience any side effects or reactions due to the vaccine.
Tuesday pm reaction "size of grapefruit" swollen, hard and red. Wednesday, redness and swelling to elbow, Thursday/Friday underlying bruise. Some "hoarsness of lungs" Real lose cough. Used ice and benedryl. Reaction in right arm.
Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination. Diagnosis was COVID-19 infection.
really bad headache in back of head; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (really bad headache in back of head), CHILLS (chills) and MYALGIA (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.     On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (really bad headache in back of head), CHILLS (chills) and MYALGIA (body aches). At the time of the report, HEADACHE (really bad headache in back of head), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
The pt experienced a rash 1-2 hours post vax. Small dots, very itchy. Rash still present on 5/14/01.
5/18/20- NAUSEA + DIARRHEA. MOSTLY DIARRHEA ALL DAY 5/19/20- SWELLING OF HANDS, ANKLES, WRIST GENERALIZED RASH - ARMS, & FROM WAIST TO KNEES. NON-PRURITIC. TREATED AT HOSPITAL WITH IV BENADRYL & NOW ON OTC Benadryl.
Developed fever, severe muscle aches and fatigue that started 2am on 2/11/21.  rested and tool Tylenol extra strength after 24 hours of symptom onset with some relief. The muscle aches were all over but especially sore in eyes, hands and ribs. By 2/12/21 muscle aches in hands, eyes and ribs plus fever had resolved. Only slight aches and fatigue continued.
Within 2 hours of vaccination, developed pain, redness and swelling (1/2 size of orange). Iced and used ibuprofen.This lasted 4-5 days. Pt later developed 5 small red lesions, each .5 cm with itching. No drainage/pus. Slow to heal, on 11/9/05, still had 3 lesions visible.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received BNT162b2 (BNT162B2), on 20Feb2021 at 12:00 as dose 1, single (Lot number: EL9267), in right arm, on 13Mar2021 at 12:00 as dose 2, single (Lot number: EN6206), in left arm and on 27Sep2021 at 16:00 as dose 3 (booster), single (Lot number: EL9267) at the age of 71 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 15Apr2022 at 16:00 as dose 4 (booster), single (Lot number: 002m21a), in right arm for covid-19 immunisation. The patient's relevant medical history included: "autoimmune" (unspecified if ongoing). Concomitant medication(s) included: CELEBREX, start date: Jan2016. Past drug history included: Cipro, reaction(s): "Known allergies: Cipro". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 14Jul2022 at 18:00, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Received treatment with Paxlovid  from 16Jul2022 to 19Jul2022.  Follow-up attempts are completed. No further information is expected.
As nurse was administering vaccine Vaxneuvance, vaccine syringe (prefilled) broke at the luer -lock hub leaving the child with a needle inside of the right thigh, needle was removed without complication leaving the child without harm